Hu J - Search Results

1

CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.

Liu M, Tsang JYS, Lee M, Ni YB, Chan SK, Cheung SY, Hu J, Hu H, Tse GMK. Liu M, et al. Among authors: hu h, hu j. J Clin Pathol. 2018 Nov;71(11):1007-1014. doi: 10.1136/jclinpath-2018-205342. Epub 2018 Aug 11. J Clin Pathol. 2018. PMID: 30099407

2

PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.

Tsang JY, Au WL, Lo KY, Ni YB, Hlaing T, Hu J, Chan SK, Chan KF, Cheung SY, Tse GM. Tsang JY, et al. Among authors: hu j. Breast Cancer Res Treat. 2017 Feb;162(1):19-30. doi: 10.1007/s10549-016-4095-2. Epub 2017 Jan 5. Breast Cancer Res Treat. 2017. PMID: 28058578

3

Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer.

Tsang JYS, Chan KW, Ni YB, Hlaing T, Hu J, Chan SK, Cheung SY, Tse GM. Tsang JYS, et al. Among authors: hu j. Ann Surg Oncol. 2017 Dec;24(13):4042-4050. doi: 10.1245/s10434-017-5924-1. Epub 2017 Jun 13. Ann Surg Oncol. 2017. PMID: 28612127

4

Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.

Liu X, Tsang JYS, Hlaing T, Hu J, Ni YB, Chan SK, Cheung SY, Tse GM. Liu X, et al. Among authors: hu j. Oncologist. 2017 Nov;22(11):1316-1324. doi: 10.1634/theoncologist.2017-0029. Epub 2017 Jul 12. Oncologist. 2017. PMID: 28701569 Free PMC article.

5

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer.

Zhou W, Zhang Y, Zhong C, Hu J, Hu H, Zhou D, Cao M. Zhou W, et al. Among authors: hu h, hu j. Cancer Manag Res. 2018 Sep 20;10:3687-3696. doi: 10.2147/CMAR.S175470. eCollection 2018. Cancer Manag Res. 2018. PMID: 30288100 Free PMC article.

6

Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.

Chen LY, Hu J, Tsang JYS, Lee MA, Ni YB, Chan SK, Tse GMK. Chen LY, et al. Among authors: hu j. Histopathology. 2019 Sep;75(3):320-328. doi: 10.1111/his.13881. Epub 2019 Jul 16. Histopathology. 2019. PMID: 31013355

7

Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features.

Li J, Tsang JY, Chen C, Chan SK, Cheung SY, Wu C, Kwong A, Hu J, Hu H, Zhou D, Tse GM. Li J, et al. Among authors: hu h, hu j. Ann Surg Oncol. 2019 Sep;26(9):2747-2758. doi: 10.1245/s10434-019-07445-1. Epub 2019 May 20. Ann Surg Oncol. 2019. PMID: 31111353

8

Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer.

Yan C, Hu J, Yang Y, Hu H, Zhou D, Ma M, Xu N. Yan C, et al. Among authors: hu h, hu j. Mol Med Rep. 2019 Nov;20(5):3991-4002. doi: 10.3892/mmr.2019.10669. Epub 2019 Sep 10. Mol Med Rep. 2019. PMID: 31545424 Free PMC article.

9

Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups.

Hu J, Fung MW, Tsang JY, Poon IK, Chan SK, Cheung SY, Hu H, Zhou D, Tse GM. Hu J, et al. Among authors: hu h. Clin Breast Cancer. 2020 Jun;20(3):253-261.e7. doi: 10.1016/j.clbc.2020.01.011. Epub 2020 Mar 20. Clin Breast Cancer. 2020. PMID: 32205037

10

Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer.

Jamidi SK, Hu J, Aphivatanasiri C, Tsang JY, Poon IK, Li JJ, Chan SK, Cheung SY, Tse GM. Jamidi SK, et al. Among authors: hu j. Histopathology. 2020 Dec;77(6):936-948. doi: 10.1111/his.14118. Epub 2020 Sep 12. Histopathology. 2020. PMID: 32304249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,601 results

Search Page

Filters